Philippines Radiotherapy Market Report 2022 to 2030

Philippines Radiotherapy Market Analysis

$ 3999

By 2030, it is anticipated that the Philippines Radiotherapy Market will reach a value of $33 Mn from $22 Mn in 2022, growing at a CAGR of 5.8% during 2022-30. The Radiotherapy Therapeutics Market in the Philippines is dominated by a few domestic players such as Advanced Radiotherapy Technologies, Elekta, and Sumitomo Heavy Industries. The radiotherapy market in the Philippines is segmented into different types, technologies, procedures, applications, and end-users. The major risk factors associated with awareness of radiotherapy shortage of skilled staff, government initiatives, and reimbursement policy. The demand for Philippines Radiotherapy is increasing on account of the rise in cancer cases in the country.

ID: IN10PHPH043 CATEGORY: Pharmaceuticals GEOGRAPHY: Phillipines AUTHOR: Dr. Vishwa Modhia

Buy Now

Philippines Radiotherapy Market Analysis Summary

By 2030, it is anticipated that the Philippines Radiotherapy Market will reach a value of $33 Mn from $22 Mn in 2022, growing at a CAGR of 5.8% during 2022-30.

Cancer is the second leading cause of mortality in the Philippines, a lower-middle-income country (LMIC) in Southeast Asia with a population of more than 110 million people. Cancer affects 189 out of every 100,000 Filipinos, according to the Department of Health (DOH), with four Filipinos dying of the deadly illness per hour, for a total of 96 cancer patients every day. In 2020 alone, cancer was responsible for approximately 150,000 new diagnoses and nearly 90,000 deaths. 1 In February 2019, the Philippine National Integrated Cancer Control Act (NICCA) was signed into law.

The NICCA includes provisions for the establishment of national and regional cancer centers, educational initiatives for healthcare professionals and laypeople, psychosocial, supportive, and palliative services, the establishment of a national cancer registry, support for training in and the conduct of cancer research ranging from basic science and clinical investigation to psychological and sociological research and expanded financial support for patients. The Philippines' government spent 5.1% of its GDP on healthcare in 2020.

Philippines Radiotherapy Market Analysis

Market Dynamics

Market Growth Drivers Analysis

The high prevalence of cancer in the Philippines is predicted to greatly raise demand for cancer treatment procedures such as radiotherapy, hence supporting the growth of the Philippines' radiotherapy market. Increasing activities by various government organisations to promote access to radiotherapy among cancer patients in the Philippines are projected to offer a profitable environment for the growth of the Philippines' radiotherapy market. For example, due to the high prevalence of cancer in the Philippines, the Department of Health (DOH) decided in 2016 to strategically build cancer centres at hospitals to make quality radiation therapy services more accessible to cancer patients, particularly those living outside Metro Manila. These aspects could boost Philippine's, Radiotherapy Market.

Market restrains.

The greatest constraint to market expansion in this region is the high cost of therapy. The expensive cost of radiotherapy technologies like as CyberKnife and Gamma Knife is expected to be one factor limiting their use, as such systems need a large investment that tiny hospitals in the Philippines cannot easily afford. These factors may deter new entrants into the Philippines Radiotherapy Market.

Competitive Landscape

Key Players

Advanced Radiotherapy Technologies (ART) - ART is a leading supplier of radiotherapy equipment in the Philippines. The company offers a range of products and services, including linear accelerators, treatment planning systems, and radiation protection solutions
Elekta - Elekta is a global company that provides advanced radiation therapy equipment and software solutions. In the Philippines, the company has a strong presence and offers a range of products, including linear accelerators, brachytherapy systems, and treatment planning software
Sumitomo Heavy Industries- Sumitomo Heavy Industries is a Japanese company that provides advanced radiation therapy equipment, including linear accelerators and proton therapy systems. The company has a presence in the Philippines and provides equipment to several healthcare facilities
Siemens Healthineers - Siemens Healthineers is a global company that provides a wide range of medical equipment and services, including radiotherapy equipment. In the Philippines, the company offers a range of products, including linear accelerators, CT scanners, and MRI machines

Healthcare Policies and Reimbursement Scenarios

In the Philippines, the regulations and reimbursement of radiotherapy are overseen by the Department of Health (DOH) and the Philippine Health Insurance Corporation (PhilHealth). In 2017, the Philippines implemented a new customs clearance procedure for radiation devices. For shipment of each radiation-emitting device in the Philippines, importers must obtain a Clearance for Customs Release (CFCR) certificate issued by the FDA’s Center for Device Regulation, Radiation Health, and Research (CDRRHR). The Philippine Society for Radiation Oncology (PSRO) is the main professional organization for radiation oncologists in the Philippines and works closely with the DOH to develop guidelines and standards of practice for radiotherapy.

1. Executive Summary
1.1 Disease Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Patient Journey
1.6 Health Insurance Coverage in Country
1.7 Active Pharmaceutical Ingredient (API)
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Epidemiology of Disease
2.2 Market Size (With Excel & Methodology)
2.3 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Radiotherapy Segmentation

By Type (Revenue, USD Billion):

External Beam Radiation Therapy
Linear Accelerators
Compact Advanced Radiotherapy Systems
Cyberknife
Gamma Knife
?Tomotherapy
Proton Therapy
Cyclotron
?Synchrotron
Internal Beam Radiation Therapy
Brachytherapy
Seeds
Applicators and Afterloaders
Electronic Brachytherapy
Systemic Radiation Therapy
?Others

?By Technology (Revenue, USD Billion):

External Beam Radiotherapy
Intensity-Modulated Radiation Therapy (IMRT)
Image-Guided Radiation Therapy (IGRT)
Stereotactic Radiation Therapy (SRT)
3D Conformal Radiation Therapy (3D-CRT)
Particle Therapy
Internal Beam Radiotherapy
Brachytherapy
High-Dose Rate Brachytherapy
Low-Dose Rate Brachytherapy
Image-Guided Brachytherapy
Pulse-Dose Rate Brachytherapy
Systemic Radiation Therapy
Intravenous Radiotherapy
Oral Radiotherapy?

By Application (Revenue, USD Billion):

Breast Cancer
Cervical Cancer
Colon and rectum Cancers
Stomach Cancer
Lung Cancer
Prostate Cancer
Skin Cancer
Liver Cancer
Other types of cancer

By End User (Revenue, USD Billion):

Hospitals
Radiotherapy Centers & Ambulatory Surgery Centers
?Cancer Research Institutes

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

Analyzing historical proprietary data collected from multiple projects.
Regularly updating our existing data sets with new findings and trends.
Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

Searching through academic conferences, published research, citations, and social media platforms
Collecting and compiling diverse data to build a comprehensive and detailed database
Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
Continuously refreshing our database to ensure that the information remains current and reliable.
Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

Merging historical data from secondary research with real-time data from primary research.
Conducting thorough data validation and cleansing to remove inconsistencies and errors.
Organizing data into a structured format that is easily accessible and usable for various applications.
Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.